** Shares of healthcare product distributor Henry Schein HSIC.O fall 1.7% to $76.31
** Co forecasts 2025 profit between $4.80 and $4.94 per share, lower than analysts' estimates of $4.99, per data compiled by LSEG
** HSIC reports Q4 profit of $1.19/share vs est of $1.21/share
** Total Q4 sales of $3.2 bln misses est of $3.29 bln
** HSIC expects revenue to grow by 2% to 4% from the $12.67 bln reported in 2024
** Stock has fallen 2.7% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。